Troy Wilson

Troy Wilson is the former CEO of San Diego-based Intellikine, which was acquired by Takeda Pharmaceuticals in 2011. Dr. Wilson was formerly co-founder and Chief Business Officer at Ambrx, a biotechnology company focused on the optimization of protein-based medicines using non-natural amino acids as well as a co-founder of Wildcat Discovery Technologies. He previously served as Vice President, Business Development and General Counsel at the Genomics Institute of the Novartis Research Foundation (GNF) in San Diego where he played a key role in the creation and launch of several spinout companies. Dr. Wilson received his Ph.D. in bioorganic chemistry from the University of California, Berkeley and his law degree from New York University.